Tag Archives: Parkinson Disease

High density microelectrode recording predicts span of therapeutic tissue activation volumes in subthalamic deep brain stimulation for Parkinson disease

Charles W.Lu et al. High density microelectrode recording predicts span of therapeutic tissue activation volumes in subthalamic deep brain stimulation for Parkinson disease. Brain Stimulation. Publication Date December 4, 2019 How Analyze was Used “The Analyze (version 12.0) software Diffusion Tensor Imaging (DTI) application was used to calculate the eigenvectors and eigenvalues of the DTI…

Finite Element Electrode and Individual Patient Modeling to Optimize Restorative Neuroengineering

Karlo A. Malaga Finite Element Electrode and Individual Patient Modeling to Optimize Restorative Neuroengineering. Ph.D. Thesis, University of Michigan. Publication Date October 5, 2019 How Analyze was Used “All image processing was performed by the same individual to minimize registration variability using Analyze, a medical imaging visualization and analysis software package (12.0, AnalyzeDirect, Inc., Overland…

Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease

Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N. Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease. Brain. July 2015. Publication Date July 2015 How Analyze was Used “Available images were loaded together with a single subject MRI template in Montreal Neurological Institute space…

Subject-specific computational modeling of DBS in the PPTg area

Zitella LM, Teplitzky BA, Yager P, Hudson HM, Brintz K, Duchin Y, Harel N, Vitek JL, Baker KB, Johnson MD. Subject-specific computational modeling of DBS in the PPTg area. Front Comput Neurosci. July 2015;9:93. Full Text – Open Access Publication Date July 2015 How Analyze was Used “The SWI volume was aligned in anterior commissure…

Loss of phosphodiesterase 10A signalling is associated with progression and severity in patients with Parkinson’s disease

Niccolini F, Foltynie T, Reis Marques T, Searle G, Natesan S, Kapur S, Rabiner E, Gunn R, Piccini P, Politis M. Loss of phosphodiesterase 10A signalling is associated with progression and severity in patients with Parkinson’s disease. Abstract. J Nucl Med. May 2015;56(supplement 3):31. Full Text – Open Access Publication Date May 2015 How Analyze…

Single versus multiple impulse control disorders in Parkinson’s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release

Wu K, Politis M, O’Sullivan SS, Lawrence AD, Warsi S, Bose S, Lees AJ, Piccini P. Single versus multiple impulse control disorders in Parkinson’s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol. April 2015. Publication Date April 2015 How Analyze was Used “Each object map was applied to…

Loss of phosphodiesterase 10A (PDE-10A) signalling is associated with progression and severity in patients with Parkinson’s disease

Niccolini F, Foltynie T, Reis Marques T, Natesan S, Kapur S, Muhlert N, Tzortzi A, Rabiner E, Gunn R, Piccini P, Politis M. Loss of phosphodiesterase 10A (PDE-10A) signalling is associated with progression and severity in patients with Parkinson’s disease. Abstract. Neurology. April 2015;84(14 Supplement). Publication Date April 2015 How Analyze was Used “Striatum (caudate and putamen)…